Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Dec 7, 2009

Nexus Biosystems Nabs Aurora Biotechnologies

  • Nexus Biosystems acquired Aurora Biotechnologies, thus expanding into high-throughput biochemical, cell-based, and genomic screening applications. The company has traditionally provided technologies and automated sample-management systems to pharmaceutical, biotech, agrichemical, and research institutions.

    Aurora serves the discovery research markets with consumable microplate products that enable high-throughput analysis of chemical compounds and cellular assays. Its offerings include a range of high-performance microplate designs including 1,536- and 3,456-well plates.   

    “Aurora’s legacy in understanding key processes in assay technologies and consumables is a great fit with the Nexus sample-management and sample-processing technologies,” Peter Coassin, president and chief technical officer of Aurora.



Related content

Be sure to take the GEN Poll

CRISPR Patent Controversy

Do you think recently released email from a former Broad Institute scientist to Jennifer Doudna will expedite a final legal decision on who owns the CRISPR patent?

More »